HuGE Literature Finder
Records
1
-
6
Clinical insights gained by refining the 2016 WHO classification of diffuse gliomas with: EGFR amplification, TERT mutations, PTEN deletion and MGMT methylation. BMC cancer 2019 Oct 19 (1): 968. Brito Cheila, Azevedo Ana, Esteves Susana, Marques Ana Rita, Martins Carmo, Costa Ilda, Mafra Manuela, Bravo Marques José M, Roque Lúcia, Pojo Mar |
Granular cell astrocytoma: an aggressive IDH-wildtype diffuse glioma with molecular genetic features of primary glioblastoma. Brain pathology (Zurich, Switzerland) 2018 Sep . Vizcaino M Adelita, Palsgrove Doreen N, Yuan Ming, Giannini Caterina, Cabrera-Aldana Eibar Ernesto, Pallavajjala Aparna, Burger Peter C, Rodriguez Fausto |
Prognostic relevance of mutations and copy number alterations assessed with targeted next generation sequencing in IDH mutant grade II glioma. Journal of neuro-oncology 2018 Apr . Wijnenga Maarten M J, French Pim J, Dubbink Hendrikus J, Dinjens Winand N M, Atmodimedjo Peggy N, Kros Johan M, Fleischeuer Ruth, Dirven Clemens M F, Vincent Arnaud J P E, van den Bent Martin |
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial. Neuro-oncology 2015 Sep . Dubbink Hendrikus J, Atmodimedjo Peggy N, Kros Johan M, French Pim J, Sanson Marc, Idbaih Ahmed, Wesseling Pieter, Enting Roelien, Spliet Wim, Tijssen Cees, Dinjens Winand N M, Gorlia Thierry, van den Bent Martin |
Targetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomas. Clinical cancer research : an official journal of the American Association for Cancer Research 2014 Jun 20 (11): 2898-909. Wakimoto Hiroaki, Tanaka Shota, Curry William T, Loebel Franziska, Zhao Dan, Tateishi Kensuke, Chen Juxiang, Klofas Lindsay K, Lelic Nina, Kim James C, Dias-Santagata Dora, Ellisen Leif W, Borger Darrell R, Fendt Sarah-Maria, Vander Heiden Matthew G, Batchelor Tracy T, Iafrate A John, Cahill Daniel P, Chi Andrew |
PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme. Journal of the National Cancer Institute 2001 Aug 93 (16): 1246-56. Smith J S, Tachibana I, Passe S M, Huntley B K, Borell T J, Iturria N, O'Fallon J R, Schaefer P L, Scheithauer B W, James C D, Buckner J C, Jenkins R |
- Page last reviewed:Oct 1, 2021
- Page last updated:Jun 28, 2022
- Content source: